Showing results (31-40 of 216) with videos related to
Sort By:
Pageof 22
Springerplus|February 4, 2015
Status migrainosus as an initial presentation of multiple sclerosisRaed Alroughani, Samar F Ahmed, Riyadh Khan, et al.CNS Drugs|July 12, 2014
Real-world use of fingolimod in patients with relapsing remitting multiple sclerosis: a retrospective study using the national multiple sclerosis registry in KuwaitJasem Al-Hashel, Samar F Ahmed, Raed Behbehani, et al.Journal of Neuroimmunology|February 21, 2019
Angiopoietin-like proteins in multiple sclerosisRabeah Al-Temaimi, Preethi Cherian, Mohamed Abu-Farha, et al.Multiple Sclerosis and Related Disorders|May 28, 2025
Ocrelizumab for pediatric relapsing multiple sclerosisRaed Alroughani, Malak AlMojel, Jasem Al-Hashel, et al.Pediatric Neurology|April 9, 2017
The Use of Natalizumab in Pediatric Patients With Active Relapsing Multiple Sclerosis: A Prospective StudyRaed Alroughani, Samar Farouk Ahmed, Raed Behbehani, et al.Frontiers in Neurology|January 21, 2025
Efficacy of onabotulinumtoxinA treatment in episodic migraineJasem Al-Hashel, Raed Alroughani, Malak Almojel, et al.Clinical Neurology and Neurosurgery|July 17, 2023
A prospective observational longitudinal study with a two-year follow-up of multiple sclerosis patients on CladribineJasem Al-Hashel, Samar Farouk Ahmed, Malak AlMojel, et al.Experimental and Molecular Pathology|November 8, 2017
Remyelination modulators in multiple sclerosis patientsRabeah Al-Temaimi, Jehad AbuBaker, Irina Al-Khairi, et al.Multiple Sclerosis and Related Disorders|August 26, 2023
Real world study of ocrelizumab in multiple sclerosis: Kuwait experienceRaed Alroughani, Malak AlMojel, Jasem Al-Hashel, et al.Multiple Sclerosis and Related Disorders|April 13, 2023
A real-life study of alemtuzumab in persons with multiple sclerosis: Kuwait's experienceRaed Alroughani, Malak AlMojel, Jasem Al-Hashel, et al.Pageof 22